Literature DB >> 25639992

Lifetime and 12-month use of psychiatric services among U.S. Army National Guard soldiers in Ohio.

David S Fink1, Laura Sampson, Marijo B Tamburrino, Israel Liberzon, Renee Slembarski, Philip Chan, Gregory H Cohen, Edwin Shirley, Toyomi Goto, Nicole D'Arcangelo, Thomas Fine, Philip Reed, Sandro Galea, Joseph R Calabrese.   

Abstract

OBJECTIVE: The individual and economic burden of psychiatric illnesses is substantial. Although treatment of psychiatric disorders mitigates the burden of illness, over half of military personnel with disorders do not receive mental health care. However, there is a paucity of research examining the relationship between psychiatric disorder categories and treatment-seeking behavior in representative military populations. This study aimed to document, by psychiatric disorder category, the annualized rate of Guard members who obtained psychiatric services and the factors associated with service utilization.
METHODS: Face-to-face clinical assessments were conducted between 2008 and 2012 to assess lifetime and current psychiatric disorders and recent psychiatric service use among 528 Ohio Army National Guard soldiers.
RESULTS: An annualized rate of 31% of persons per year accessed psychiatric services between 2010 and 2012. Persons with substance use disorders had the lowest annualized rate of service use, and these were the only disorders not predictive of accessing services. Current mood disorder, current anxiety disorder, and lifetime history of service use were the strongest predictors of recent service use. There were no socioeconomic or other group predictors of psychiatric service use.
CONCLUSIONS: About half of the soldiers who could benefit from mental health services used them, yet soldiers with substance use disorders were predominantly going untreated. There were no differences in treatment utilization by group characteristics, suggesting no systematic barriers to care for particular groups. Efforts to encourage broader adoption of treatment seeking, particularly among persons with substance use disorders, are necessary to mitigate psychiatric health burden in this population.

Entities:  

Mesh:

Year:  2015        PMID: 25639992     DOI: 10.1176/appi.ps.201400128

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  5 in total

1.  Determinants of National Guard Mental Health Service Utilization in VA versus Non-VA Settings.

Authors:  Lisa A Gorman; Rebecca K Sripada; Dara Ganoczy; Heather M Walters; Kipling M Bohnert; Gregory W Dalack; Marcia Valenstein
Journal:  Health Serv Res       Date:  2016-02-03       Impact factor: 3.402

2.  Evaluation of Proactive Community Case Detection to Increase Help Seeking for Mental Health Care: A Pragmatic Randomized Controlled Trial.

Authors:  Mark J D Jordans; Nagendra P Luitel; Crick Lund; Brandon A Kohrt
Journal:  Psychiatr Serv       Date:  2020-04-23       Impact factor: 3.084

3.  Prevalence and predictors of no lifetime utilization of mental health treatment among people with mental disorders in France: findings from the 'Mental Health in General Population' (MHGP) survey.

Authors:  Hélène Font; Jean-Luc Roelandt; Hélène Behal; Pierre-Alexis Geoffroy; Baptiste Pignon; Ali Amad; Nicolas Simioni; Guillaume Vaiva; Pierre Thomas; Alain Duhamel; Imane Benradia; Benjamin Rolland
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-04-04       Impact factor: 4.328

4.  Resilience to mental health problems and the role of deployment status among U.S. Army Reserve and National Guard Soldiers.

Authors:  Rachel A Hoopsick; D Lynn Homish; R Lorraine Collins; Thomas H Nochajski; Jennifer P Read; Paul T Bartone; Gregory G Homish
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-06-18       Impact factor: 4.519

5.  Influence of military component and deployment-related experiences on mental disorders among Canadian military personnel who deployed to Afghanistan: a cross-sectional survey.

Authors:  David Boulos; Deniz Fikretoglu
Journal:  BMJ Open       Date:  2018-03-12       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.